Obesema 2.4mg Injection is used along with a reduced-calorie diet and regular physical activity for:

• Weight management in adults with obesity.

• Weight management in adults who are overweight and have at least one weight-related health condition.

Semaglutide treatment should be used as part of an overall weight-management plan rather than as a replacement for healthy eating and physical activity.

Semaglutide is a GLP-1 receptor agonist. It acts in a similar way to the naturally occurring GLP-1 hormone and affects areas of the brain involved in appetite regulation. This can increase feelings of fullness and reduce hunger, food intake and cravings.

Semaglutide also slows the movement of food through the stomach and influences blood glucose regulation. Together, these effects can support reduced calorie intake and weight loss when used with diet and physical activity.

Tell your doctor about all the medicines you take before starting Obesema 2.4mg Injection.

• Other semaglutide-containing medicines: Using more than one medicine containing semaglutide is not recommended.

• Other GLP-1 receptor agonists: Combining Obesema with another GLP-1 receptor agonist is not recommended.

• Insulin or sulfonylureas: If used with medicines that can lower blood glucose, the risk of hypoglycaemia may increase, particularly in people with diabetes.

• Medicines taken by mouth: Semaglutide can slow stomach emptying and may affect the absorption of some medicines taken orally. Tell your doctor about medicines that require close monitoring.

• Store Obesema 2.4mg Injection in a refrigerator at 2°C to 8°C.

• Do not freeze the medicine.

• Keep it away from direct heat and light.

• Keep it out of the reach of children.

• Do not use the medicine if it has been frozen or if the solution appears abnormal.

Obesema 2.4mg Injection is given as a subcutaneous injection, usually into the abdomen, thigh or upper arm. It is administered once a week, preferably on the same day each week. It can be used at any time of day, with or without food. 

The 2.4mg strength is a maintenance dose for semaglutide weight-management treatment. Treatment is generally started at a lower dose and increased gradually to reduce gastrointestinal side effects. Do not start treatment directly at 2.4mg or change your dose unless your doctor has instructed you to do so.

The most common side effects of semaglutide include:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Abdominal pain

• Headache

These effects are particularly common when treatment is started or the dose is increased and may improve as the body adjusts to treatment.

Seek medical attention if you develop severe or persistent abdominal pain, symptoms of a serious allergic reaction, significant changes in vision or symptoms suggesting severe dehydration. Semaglutide has also been associated with important but less common risks such as pancreatitis, gallbladder problems and diabetic retinopathy complications.

• Use Obesema exactly as prescribed and do not increase the dose on your own.

• Follow the prescribed dose-escalation schedule before reaching the 2.4mg maintenance dose.

• Continue with the reduced-calorie diet and physical activity recommended by your healthcare professional.

• Eat smaller meals if nausea or fullness becomes uncomfortable.

• Drink enough fluids, particularly if vomiting or diarrhoea occurs.

• Do not use Obesema together with another semaglutide-containing medicine or another GLP-1 receptor agonist unless specifically directed by your doctor.

• Tell your healthcare team that you are using semaglutide before planned surgery or deep sedation.